Toyota is expected to report a 5% drop in quarterly operating profit, marking its fifth straight decline, as falling overseas sales and rising costs weigh on earnings. Investors are now also focused on the impact of recent earthquake-related production halts in Japan.
Russia's main stock benchmark, the MOEX Russia Index, closed with a 0.75% gain, propelled by strong performance in the mining, power, and oil & gas sectors. The advance came as oil prices rose and the ruble strengthened against major currencies.
Pharmaceutical giants AstraZeneca and Bristol-Myers Squibb have held preliminary merger talks that could create a combined entity worth nearly $400 billion, according to a Financial Times report.
According to analysts at Bernstein, SpaceX's future valuation is critically dependent on achieving rapid Starship reusability, securing semiconductor and compute capacity, and navigating complex regulatory environments.
UK drugmaker AstraZeneca has reportedly held talks with U.S. rival Bristol Myers Squibb about a potential combination that would create a pharmaceutical giant with a combined value of nearly $400 billion.
An analyst at Capital Economics suggests the UK stock market could outperform global peers in a potential AI-driven downturn, citing its minimal technology sector exposure compared to the dot-com era.
JPMorgan analysts are constructive on European equities, citing improving earnings, attractive valuations compared to the U.S., and rising M&A and shareholder activism as key catalysts for growth.
Saudi Arabian stocks closed higher on Sunday, with the benchmark Tadawul All Share index advancing 1.10%, driven by broad-based gains in sectors like insurance and construction amid rising crude oil prices.
The widespread use of GLP-1 weight-loss medications is prompting a significant number of consumers to return to physical stores to find new clothing sizes, presenting both an opportunity and a challenge for apparel retailers.
